Literature DB >> 30560910

Advancing an HIV vaccine; advancing vaccinology.

Dennis R Burton1,2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30560910      PMCID: PMC6425752          DOI: 10.1038/s41577-018-0103-6

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


× No keyword cloud information.
  9 in total

1.  HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen.

Authors:  Joseph G Jardine; Daniel W Kulp; Colin Havenar-Daughton; Anita Sarkar; Bryan Briney; Devin Sok; Fabian Sesterhenn; June Ereño-Orbea; Oleksandr Kalyuzhniy; Isaiah Deresa; Xiaozhen Hu; Skye Spencer; Meaghan Jones; Erik Georgeson; Yumiko Adachi; Michael Kubitz; Allan C deCamp; Jean-Philippe Julien; Ian A Wilson; Dennis R Burton; Shane Crotty; William R Schief
Journal:  Science       Date:  2016-03-25       Impact factor: 47.728

2.  Precursor Frequency and Affinity Determine B Cell Competitive Fitness in Germinal Centers, Tested with Germline-Targeting HIV Vaccine Immunogens.

Authors:  Robert K Abbott; Jeong Hyun Lee; Sergey Menis; Patrick Skog; Meghan Rossi; Takayuki Ota; Daniel W Kulp; Deepika Bhullar; Oleksandr Kalyuzhniy; Colin Havenar-Daughton; William R Schief; David Nemazee; Shane Crotty
Journal:  Immunity       Date:  2017-12-26       Impact factor: 31.745

3.  Anti-HIV-1 B cell responses are dependent on B cell precursor frequency and antigen-binding affinity.

Authors:  Pia Dosenovic; Ervin E Kara; Anna-Klara Pettersson; Andrew T McGuire; Matthew Gray; Harald Hartweger; Eddy S Thientosapol; Leonidas Stamatatos; Michel C Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-16       Impact factor: 11.205

4.  Glycan Masking Focuses Immune Responses to the HIV-1 CD4-Binding Site and Enhances Elicitation of VRC01-Class Precursor Antibodies.

Authors:  Hongying Duan; Xuejun Chen; Jeffrey C Boyington; Cheng Cheng; Yi Zhang; Alexander J Jafari; Tyler Stephens; Yaroslav Tsybovsky; Oleksandr Kalyuzhniy; Peng Zhao; Sergey Menis; Martha C Nason; Erica Normandin; Maryam Mukhamedova; Brandon J DeKosky; Lance Wells; William R Schief; Ming Tian; Frederick W Alt; Peter D Kwong; John R Mascola
Journal:  Immunity       Date:  2018-07-31       Impact factor: 31.745

Review 5.  Strategies for a multi-stage neutralizing antibody-based HIV vaccine.

Authors:  Raiees Andrabi; Jinal N Bhiman; Dennis R Burton
Journal:  Curr Opin Immunol       Date:  2018-05-16       Impact factor: 7.486

Review 6.  Progress toward active or passive HIV-1 vaccination.

Authors:  Amelia Escolano; Pia Dosenovic; Michel C Nussenzweig
Journal:  J Exp Med       Date:  2016-12-21       Impact factor: 14.307

7.  Electron-Microscopy-Based Epitope Mapping Defines Specificities of Polyclonal Antibodies Elicited during HIV-1 BG505 Envelope Trimer Immunization.

Authors:  Matteo Bianchi; Hannah L Turner; Bartek Nogal; Christopher A Cottrell; David Oyen; Matthias Pauthner; Raiza Bastidas; Rebecca Nedellec; Laura E McCoy; Ian A Wilson; Dennis R Burton; Andrew B Ward; Lars Hangartner
Journal:  Immunity       Date:  2018-08-07       Impact factor: 31.745

8.  Vaccine-Induced Protection from Homologous Tier 2 SHIV Challenge in Nonhuman Primates Depends on Serum-Neutralizing Antibody Titers.

Authors:  Matthias G Pauthner; Joseph P Nkolola; Colin Havenar-Daughton; Ben Murrell; Samantha M Reiss; Raiza Bastidas; Jérémie Prévost; Rebecca Nedellec; Benjamin von Bredow; Peter Abbink; Christopher A Cottrell; Daniel W Kulp; Talar Tokatlian; Bartek Nogal; Matteo Bianchi; Hui Li; Jeong Hyun Lee; Salvatore T Butera; David T Evans; Lars Hangartner; Andrés Finzi; Ian A Wilson; Richard T Wyatt; Darrell J Irvine; William R Schief; Andrew B Ward; Rogier W Sanders; Shane Crotty; George M Shaw; Dan H Barouch; Dennis R Burton
Journal:  Immunity       Date:  2018-12-11       Impact factor: 31.745

9.  Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1.

Authors:  Kai Xu; Priyamvada Acharya; Rui Kong; Cheng Cheng; Gwo-Yu Chuang; Kevin Liu; Mark K Louder; Sijy O'Dell; Reda Rawi; Mallika Sastry; Chen-Hsiang Shen; Baoshan Zhang; Tongqing Zhou; Mangaiarkarasi Asokan; Robert T Bailer; Michael Chambers; Xuejun Chen; Chang W Choi; Venkata P Dandey; Nicole A Doria-Rose; Aliaksandr Druz; Edward T Eng; S Katie Farney; Kathryn E Foulds; Hui Geng; Ivelin S Georgiev; Jason Gorman; Kurt R Hill; Alexander J Jafari; Young D Kwon; Yen-Ting Lai; Thomas Lemmin; Krisha McKee; Tiffany Y Ohr; Li Ou; Dongjun Peng; Ariana P Rowshan; Zizhang Sheng; John-Paul Todd; Yaroslav Tsybovsky; Elise G Viox; Yiran Wang; Hui Wei; Yongping Yang; Amy F Zhou; Rui Chen; Lu Yang; Diana G Scorpio; Adrian B McDermott; Lawrence Shapiro; Bridget Carragher; Clinton S Potter; John R Mascola; Peter D Kwong
Journal:  Nat Med       Date:  2018-06-04       Impact factor: 53.440

  9 in total
  41 in total

1.  Mutational fitness landscapes reveal genetic and structural improvement pathways for a vaccine-elicited HIV-1 broadly neutralizing antibody.

Authors:  Bharat Madan; Baoshan Zhang; Kai Xu; Cara W Chao; Sijy O'Dell; Jacy R Wolfe; Gwo-Yu Chuang; Ahmed S Fahad; Hui Geng; Rui Kong; Mark K Louder; Thuy Duong Nguyen; Reda Rawi; Arne Schön; Zizhang Sheng; Rajani Nimrania; Yiran Wang; Tongqing Zhou; Bob C Lin; Nicole A Doria-Rose; Lawrence Shapiro; Peter D Kwong; Brandon J DeKosky
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-09       Impact factor: 11.205

Review 2.  Subdominance in Antibody Responses: Implications for Vaccine Development.

Authors:  Gunnar Lindahl
Journal:  Microbiol Mol Biol Rev       Date:  2020-11-25       Impact factor: 11.056

3.  Ending the Human Immunodeficiency Virus Pandemic: Optimizing the Prevention and Treatment Toolkits.

Authors:  Robert W Eisinger; Gregory K Folkers; Anthony S Fauci
Journal:  Clin Infect Dis       Date:  2019-11-27       Impact factor: 9.079

4.  Simian Immunodeficiency Virus Infection Modulates CD94+ (KLRD1+) NK Cells in Rhesus Macaques.

Authors:  Daniel R Ram; Olivier Lucar; Brady Hueber; R Keith Reeves
Journal:  J Virol       Date:  2019-07-30       Impact factor: 5.103

5.  Allelic polymorphism controls autoreactivity and vaccine elicitation of human broadly neutralizing antibodies against influenza virus.

Authors:  Maya Sangesland; Alba Torrents de la Peña; Seyhan Boyoglu-Barnum; Larance Ronsard; Faez Amokrane Nait Mohamed; Thalia Bracamonte Moreno; Ralston M Barnes; Daniel Rohrer; Nils Lonberg; Musie Ghebremichael; Masaru Kanekiyo; Andrew Ward; Daniel Lingwood
Journal:  Immunity       Date:  2022-08-10       Impact factor: 43.474

6.  Diversity in immunogenomics: the value and the challenge.

Authors:  Houda Alachkar; Cathrine Scheepers; Corey T Watson; Gunilla B Karlsson Hedestam; Serghei Mangul; Kerui Peng; Yana Safonova; Mikhail Shugay; Alice B Popejoy; Oscar L Rodriguez; Felix Breden; Petter Brodin; Amanda M Burkhardt; Carlos Bustamante; Van-Mai Cao-Lormeau; Martin M Corcoran; Darragh Duffy; Macarena Fuentes-Guajardo; Ricardo Fujita; Victor Greiff; Vanessa D Jönsson; Xiao Liu; Lluis Quintana-Murci; Maura Rossetti; Jianming Xie; Gur Yaari; Wei Zhang; Malak S Abedalthagafi; Khalid O Adekoya; Rahaman A Ahmed; Wei-Chiao Chang; Clive Gray; Yusuke Nakamura; William D Lees; Purvesh Khatri
Journal:  Nat Methods       Date:  2021-06       Impact factor: 47.990

Review 7.  Tailoring Materials for Modulation of Macrophage Fate.

Authors:  Jinhua Li; Xinquan Jiang; Hongjun Li; Michael Gelinsky; Zhen Gu
Journal:  Adv Mater       Date:  2021-02-09       Impact factor: 32.086

Review 8.  From Structural Studies to HCV Vaccine Design.

Authors:  Itai Yechezkel; Mansun Law; Netanel Tzarum
Journal:  Viruses       Date:  2021-05-04       Impact factor: 5.818

Review 9.  Riboswitches for Controlled Expression of Therapeutic Transgenes Delivered by Adeno-Associated Viral Vectors.

Authors:  Zachary J Tickner; Michael Farzan
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-10

Review 10.  HIV vaccinology: 2021 update.

Authors:  Jeong Hyun Lee; Shane Crotty
Journal:  Semin Immunol       Date:  2021-07-14       Impact factor: 10.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.